Advancing leprosy risk prediction through identification of a whole blood host transcriptomic biomarker signature including non-coding genes
Source check: Source checked. Not independent scientific confirmation.
Finding: The study reports a three-gene signature (SNHG5, SNHG8 and C6orf48) for distinguishing progressors from household contacts, with high reported AUC in discovery and follow-up analyses. RT-qPCR tested selected genes in a separate cohort of 12 progressors and 12 household contacts; 12 of 14 tested genes were confirmed. This is a small single-region validation and not a validated clinical diagnostic.
Technology: Random-forest and support-vector-machine feature selection on blood RNA-seq data identified a candidate host-transcriptomic signature associated with leprosy progression.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Random-forest and support-vector-machine feature selection on blood RNA-seq data identified a candidate host-transcriptomic signature associated with leprosy progression.
- Test and result
- The study reports a three-gene signature (SNHG5, SNHG8 and C6orf48) for distinguishing progressors from household contacts, with high reported AUC in discovery and follow-up analyses.
- Limitation / still unknown
- RT-qPCR tested selected genes in a separate cohort of 12 progressors and 12 household contacts; 12 of 14 tested genes were confirmed. This is a small single-region validation and not a validated clinical diagnostic.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41598-025-33878-8.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.